
    
      This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal
      outcome of all women who were treated with Corifollitropin Alfa or recFSH and became pregnant
      during Base Trial P05787 (NCT00696800). For this trial, no study specific assessments are
      required, but information as obtained in standard practice will be used.
    
  